Conference abstract · 24 Aug 2022
Short communicationPublished 21 Sep 2020
miRNA based advanced differentiation therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is a disease of the genome. For a long time, it has been established that cancer mutations are determinant to induce tumor genesis, but recent evidences also point to epigenetic alterations as direct causes of cancer. It is now widely accepted that epigenetic changes are key in the reprogramming of stem and somatic cells into cancer stem cells (CSCs), which constitute the only subset of cancer cells truly immortal and capable of supporting cancer progression. Recent evidences from our group have demonstrated how miRNAs act as potent drivers from pluripotency to expanded differentiation potential, while they block reprogramming from somatic to stem cells. Mechanistically, we have described that these effects are mediated by direct repression of de novo DNA methyltransferases (Dnmt3a and Dnmt3b), leading to a resetting of the epigenetic memory. Given that experimental induction of pluripotency and tumor genesis entail obvious similar pathways, here we speculate that epigenetic changes induced by such miRNAs might unlock the cellular differentiation programs that are normally inactivated in cancer stem cells and at the same time, block the reprogramming from somatic to cancer stem cells, therefore dropping the CSC population in the tumor. Our hypothesis, if confirmed, would shed light on the differentiation-based antitumoral therapy and present those microRNAs as a promising tool for directly confronting the tumormaintaining and regeneration capability of cancer cells.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 23 Jul 2022
MiRNAs related with the cell cycle as targets and therapies in lung cancer treatment
Conference abstract · 17 Oct 2016
Exploiting the role of exosomes and microRNAs (miRNAs) for pancreatic cancer therapy
Conference abstract · 1 Sep 2015
Cox-2 elevates oncogenic mir-526b in breast cancer by ep4 activation and this mirna is a promising biomarker for monitoring and personalizing breast cancer therapy
Article · 31 Jul 2026
Nanohybrid-Based Drug Delivery Systems in Cancer Therapy: Advances in Targeted Delivery, Controlled Release, and Translational Challenges
More from this journal
The newest in Journal of Oncology Translational Research.
Research article · 15 May 2026
Pan-cancer analysis of molecular characteristics and oncogenic role of PRMT5 in human cancers
Research article · 15 Dec 2025
Cardiac Substructure Analysis of Radiation-associated Cardiac Disease in Thoracic Malignancy Patients
Brief report · 29 Nov 2025
CDx: Navigating Global Regulations for Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Oncology Translational Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Maria Salazar Roa”

